Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

Journal of Clinical Oncology

Volumn 12, Issue 11, 1994, Pages 2271-2276

  Einhorn, Lawrence H ^a   Roth, Bruce J ^b   Ansari, Rafat ^b   Dreicer, Rob ^b   Gonin, Rene ^b   Loehrer, Patrick J ^b  

^a University of Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; GALLIUM NITRATE; IFOSFAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; BLADDER CARCINOMA; BRAIN DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; GRANULOCYTOPENIA; HUMAN; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSITIONAL BLINDNESS; UROTHELIUM;

EID: 0028113637     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.11.2271     Document Type: Article

References (21)

1. Yagoda A, Watson RC, Gonzales-Vitale JC, et al: Cisdichlorodiammineplatinum II in advanced bladder cancer. Cancer Treat Rep 60:917-923, 1976
2. Oliver RTD, Newlands ES. Wiltshaw E, et al: A phase II study of cisplatinum in patients with recurrent bladder carcinoma. Br J Urol 53:444-447, 1981
3. Soloway MS, Ikard M, Ford K: Cisdiamminedichloroplatinum (II) in locally advanced and metastatic transitional cell carcinoma. J Urol 123:375-377, 1980
4. Harker WG, Meyers FJ, Freiha FS, et al: Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract: A Northern California Oncology Group Study. J Clin Oncol 3:1463-1470, 1985
5. Sternberg CN, Yagoda A, Scher HI, et al: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Cancer 64:2448-2458, 1989
6. Loehrer PJ, Einhorn LH, Elson PJ, et al: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol 10:1066-1073, 1992
7. Soloway MS, Einstein A, Corder MP. et al: A comparison of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Cooperative Group A Study. Cancer 52:767-772, 1983
8. Troner M, Birch R, Omura GA, et al: Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: A Southeastern Cancer Study Group Trial. J Urol 137:660-662, 1987
9. Khandekar JD, Elson PJ, DeWys WD, et al: Comparative activity and toxicity of Cisdiamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide and DDP in disseminated transitional cell carcinoma of the urinary tract. J Clin Oncol 3:539-545, 1985
10. Seidman AD, Scher HI, Heinemann MH, et al: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer 68:1561-1565, 1991
11. Seligman PA, and Crawford ED: Treatment of advanced transitional cell carcinoma of the bladder with continuous infusion gallium nitrate. J Natl Cancer Inst 83:1582-1584, 1991
12. Witte R, Loehrer P, Dreicer R, et al: Ifosfamide in advanced urothelial carcinoma: An ECOG trial. Proc Am Soc Clin Oncol 12:230, 1993 (abstr)
13. Blumenreich MS, Yagoda A, Natale RB, et al: Phase II trials of vinblastine sulfate for metastatic urothelial tract tumors. Cancer 50:435-438, 1982
14. Zar JH: Biostatistical Analysis (ed 2). Englewood Cliffs, NJ, Prentice Hall, 1984, p 378
15. Mehta CR, Patel NR: A network algorithm for the exact treatment of Fisher's exact test in RxC continengency tables. J Am Stat Assoc 78:427-434, 1983
16. Agresti A: Categorical data analysis. New York, NY, Wiley, 1990, pp. 100-102
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Logothetis CJ, Dexeus FH, Finn L, et al: A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol 8:1050-1055, 1990
19. Hillcoat BL, Raghavan D, Matthews J, et al: A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. J Clin Oncol 7:706-709, 1989
20. Saiers JH, Baker LH, Costanzi JH, et al: Treatment of metastatic bladder cancer with gallium nitrate. Presented at the Thirteenth International Congress of Chemotherapy, Vienna, Austria, 1983
21. Loehrer PJ, Nichols CR, Elson P, et al: Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus rh G-CSF in advanced urothelial carcinoma. An ECOG trial. J Clin Oncol 12:483-488, 1994